Literature DB >> 14971660

Reduced Fhit protein expression in nickel-transformed mouse cells and in nickel-induced murine sarcomas.

Renata Kowara1, Konstantin Salnikow, Bhalchandra A Diwan, Robert M Bare, Michael P Waalkes, Kazimierz S Kasprzak.   

Abstract

Nickel compounds are carcinogenic and induce malignant transformation of cultured cells. Since nickel has low mutagenic potential, it may act predominantly through epigenetic mechanisms, including down-regulation of tumor suppressor genes. FHIT is a tumor suppressor gene whose expression is frequently reduced or lost in tumors and pre-malignant lesions. Previously, we have shown that the phosphohydrolase activity of Fhit protein, associated with its tumor suppressor action, is inhibited by nickel. In cells, such effect would assist in carcinogenesis. The latter could be further enhanced if nickel also lowered cellular levels of Fhit protein itself, e.g. by down-regulation of FHIT gene. To test this possibility, we determined Fhit protein and Fhit-mRNA levels in a nickel-transformed mouse cell line and in nickel-induced murine sarcomas. In B200 cells, derived by nickel treatment of BALB/c-3T3 cells and exhibiting a malignant phenotype, Fhit protein levels were 50% of those in the parental cells, while Fhit-mRNA expression remained unchanged. A decrease of up to > 90% in Fhit protein levels was also observed in 22 local sarcomas (mostly fibrosarcomas) induced by i.m. injection of nickel subsulfide in C57BL/6 and MT+ (C57BL/6 overexpressing metallothionein) mice, as compared with normal muscles. Moreover, Fhit was absent in 3 out of 10 sarcomas from MT+ mice and in 1 of 12 sarcomas from C57BL/6 mice. The lack of Fhit protein coincided with the absence of the Fhit-mRNA transcript in these tumors. However, in the other tumors, the decreased Fhit levels were not always accompanied by reduced expression of Fhit-mRNA. Thus, the observed lowering of Fhit protein levels is mostly associated with changes in mRNA expression and protein translation or turnover rates, and rarely with a full silencing of the gene itself. Overall, the decline of Fhit in cells or tissues malignantly transformed by nickel may indicate possible involvement of this effect in the mechanisms of nickel carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14971660     DOI: 10.1023/b:mcbi.0000007275.22785.91

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  37 in total

1.  Clinicopathological significance of fragile histidine triad transcription protein expression in breast carcinoma.

Authors:  Q Yang; G Yoshimura; T Suzuma; T Tamaki; T Umemura; M Nakamura; Y Nakamura; X Wang; I Mori; T Sakurai; K Kakudo
Journal:  Clin Cancer Res       Date:  2001-12       Impact factor: 12.531

2.  Aberration of FHIT gene is associated with increased tumor proliferation and decreased apoptosis-clinical evidence in lung and head and neck carcinomas.

Authors:  K Pavelić; S Krizanac; T Cacev; M P Hadzija; S Radosević; I Crnić; S Levanat; S Kapitanović
Journal:  Mol Med       Date:  2001-07       Impact factor: 6.354

3.  Role of FHIT in human cancer.

Authors:  C M Croce; G Sozzi; K Huebner
Journal:  J Clin Oncol       Date:  1999-05       Impact factor: 44.544

4.  Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expression.

Authors:  N S Werner; Z Siprashvili; L Y Fong; G Marquitan; J K Schröder; W Bardenheuer; S Seeber; K Huebner; J Schütte; B Opalka
Journal:  Cancer Res       Date:  2000-06-01       Impact factor: 12.701

5.  In vitro inhibition of the enzymatic activity of tumor suppressor FHIT gene product by carcinogenic transition metals.

Authors:  Renata Kowara; Aldona A Karaczyn; Matthew J Fivash; Kazimierz S Kasprzak
Journal:  Chem Res Toxicol       Date:  2002-03       Impact factor: 3.739

6.  Characterization of metallothionein-I-transgenic mice.

Authors:  M B Iszard; J Liu; Y Liu; T Dalton; G K Andrews; R D Palmiter; C D Klaassen
Journal:  Toxicol Appl Pharmacol       Date:  1995-08       Impact factor: 4.219

7.  Hydroxylation of deoxyguanosine at the C-8 position by ascorbic acid and other reducing agents.

Authors:  H Kasai; S Nishimura
Journal:  Nucleic Acids Res       Date:  1984-02-24       Impact factor: 16.971

8.  Characterization of mouse cell lines resistant to nickel(II) ions.

Authors:  X W Wang; R J Imbra; M Costa
Journal:  Cancer Res       Date:  1988-12-01       Impact factor: 12.701

9.  Fhit, a putative tumor suppressor in humans, is a dinucleoside 5',5"'-P1,P3-triphosphate hydrolase.

Authors:  L D Barnes; P N Garrison; Z Siprashvili; A Guranowski; A K Robinson; S W Ingram; C M Croce; M Ohta; K Huebner
Journal:  Biochemistry       Date:  1996-09-10       Impact factor: 3.162

Review 10.  Possible role of oxidative damage in metal-induced carcinogenesis.

Authors:  K S Kasprzak
Journal:  Cancer Invest       Date:  1995       Impact factor: 2.176

View more
  8 in total

Review 1.  The role of cadmium and nickel in estrogen receptor signaling and breast cancer: metalloestrogens or not?

Authors:  Natalie B Aquino; Mary B Sevigny; Jackielyn Sabangan; Maggie C Louie
Journal:  J Environ Sci Health C Environ Carcinog Ecotoxicol Rev       Date:  2012       Impact factor: 3.781

Review 2.  Carcinogenic effect of nickel compounds.

Authors:  Haitian Lu; Xianglin Shi; Max Costa; Chuanshu Huang
Journal:  Mol Cell Biochem       Date:  2005-11       Impact factor: 3.396

3.  Hypoxia and nickel inhibit histone demethylase JMJD1A and repress Spry2 expression in human bronchial epithelial BEAS-2B cells.

Authors:  Haobin Chen; Thomas Kluz; Ronghe Zhang; Max Costa
Journal:  Carcinogenesis       Date:  2010-09-29       Impact factor: 4.944

Review 4.  Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium.

Authors:  Konstantin Salnikow; Anatoly Zhitkovich
Journal:  Chem Res Toxicol       Date:  2007-10-30       Impact factor: 3.739

5.  Nickel ions inhibit histone demethylase JMJD1A and DNA repair enzyme ABH2 by replacing the ferrous iron in the catalytic centers.

Authors:  Haobin Chen; Nitai Charan Giri; Ronghe Zhang; Kenichi Yamane; Yi Zhang; Michael Maroney; Max Costa
Journal:  J Biol Chem       Date:  2009-12-30       Impact factor: 5.157

6.  Histone Methylation in Nickel-Smelting Industrial Workers.

Authors:  Li Ma; Yana Bai; Hongquan Pu; Faxiang Gou; Min Dai; Hui Wang; Jie He; Tongzhang Zheng; Ning Cheng
Journal:  PLoS One       Date:  2015-10-16       Impact factor: 3.240

Review 7.  Influence of toxicologically relevant metals on human epigenetic regulation.

Authors:  Hyun-Wook Ryu; Dong Hoon Lee; Hye-Rim Won; Kyeong Hwan Kim; Yun Jeong Seong; So Hee Kwon
Journal:  Toxicol Res       Date:  2015-03

Review 8.  Nickel: Human Health and Environmental Toxicology.

Authors:  Giuseppe Genchi; Alessia Carocci; Graziantonio Lauria; Maria Stefania Sinicropi; Alessia Catalano
Journal:  Int J Environ Res Public Health       Date:  2020-01-21       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.